A recent study in Science reveals that equilibrative nucleoside transporter 3 (ENT3) is essential for both lysosomal function and macrophage homeostasis. Similarly to patients with lysosomal storage disease owing to ENT3 mutations, ENT3-deficient mice were found to develop splenomegaly as a result of increased macrophage proliferation (histiocytosis). In the absence of functional ENT3, nucleosides accumulated in the lysosomes, leading to lysosomal alkalization. This, in turn, compromised lysosomal function, as indicated by a delay in the degradation of apoptotic cells and live bacteria by ENT3-deficient macrophages. Furthermore, the lysosomal degradation of the macrophage colony-stimulating factor 1 (CSF1)–CSF1 receptor complex was impaired in ENT3-deficient macrophages, resulting in persistent CSF1-mediated signalling, which was suggested to underlie the increase in macrophage proliferation. These findings suggest a link between lysosomal storage disease and macrophage histiocytosis.
ORIGINAL RESEARCH PAPER
Hsu, C.-L. et al. Equilibrative nucleoside transporter 3 deficiency perturbs lysosome function and macrophage homeostasis. Science 335, 89–92 (2012)Article
Rights and permissions
About this article
Cite this article
Papatriantafyllou, M. Linking lysosome function to macrophage homeostasis. Nat Rev Immunol 12, 74 (2012). https://doi.org/10.1038/nri3165
Published:
Issue Date:
DOI: https://doi.org/10.1038/nri3165